Aspyra, Inc. (AMEX:APY) announced today that the Company has contracted with Elite Lab Services, an independent clinical reference laboratory in Tyler, Texas, to provide Aspyra๏ฟฝs CyberLAB๏ฟฝ Laboratory Information System (LIS) solution. Jerry Dengler, President of Elite Lab Services stated, ๏ฟฝAfter reviewing numerous laboratory information systems, Aspyra was the only system offering the functionality we need to run a demanding reference laboratory.๏ฟฝ He continued, ๏ฟฝEvery laboratory๏ฟฝs objective is to deliver patient results quickly and accurately to physicians and nursing homes. Aspyra๏ฟฝs CyberLAB system processes our business uniquely so we can meet our objectives with custom result handling and routing tools.๏ฟฝ ๏ฟฝReference laboratories have specific workflow and report handling requirements,๏ฟฝ stated Michelle Del Guercio, Aspyra๏ฟฝs Director of Marketing and Product Management. She continued, ๏ฟฝAspyra๏ฟฝs CyberLAB solution enables Elite Lab Services to cater to their physician base with features such as customized clinical report formats, client specific decision support tools, and turnaround management reports. We look forward to working with Elite Lab Services as they extend their reach in their community.๏ฟฝ Aspyra๏ฟฝs CyberLAB๏ฟฝ LIS system is a scalable, feature-rich, and proven LIS solution for the hospital, clinic, and reference laboratory settings. CyberLAB LIS features decision support tools with auto-verification, automated clinical reporting and multisite management. About Aspyra Aspyra is a global provider of Health Care Information Technology (HCIT) solutions and services to the healthcare industry. The Company specializes in Clinical Information Systems (CIS), Picture Archive Communication Systems (PACS) and Clinical Image Management Systems (CIMS) for hospitals, multi-specialty clinics, clinical laboratories, imaging departments and centers and orthopedic environments. Aspyra's highly scalable systems can be installed standalone or integrated to provide a single-vendor, enterprise-wide solution. For more information on Aspyra, its products and services, visit www.aspyra.com. Safe Harbor Statement This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statement. Such statements are based upon, among other things, assumptions made by, and information currently available to, management as of the date of this release, including management's own knowledge and assessment of the Company's industry, customers and competition. Factors that could cause Aspyra's actual results to differ materially from these forward-looking statements include among others: changes in the Company๏ฟฝs management or other personnel, the competitive environment for Company products and services; unexpected technical and marketing difficulties inherent in major product development efforts; the potential need for changes in the Company๏ฟฝs long-term strategy in response to future developments; future advances in clinical information technology and procedures, as well as potential changes in government regulations and healthcare policies; and rapid technological change in the microelectronics and software industries. The Company refers interested persons to its most recent Annual Report on Form 10-KSB and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.
Aspyra (AMEX:APY)
๊ณผ๊ฑฐ ๋ฐ์ดํ„ฐ ์ฃผ์‹ ์ฐจํŠธ
๋ถ€ํ„ฐ 12์›”(12) 2024 ์œผ๋กœ 1์›”(1) 2025 Aspyra ์ฐจํŠธ๋ฅผ ๋” ๋ณด๋ ค๋ฉด ์—ฌ๊ธฐ๋ฅผ ํด๋ฆญ.
Aspyra (AMEX:APY)
๊ณผ๊ฑฐ ๋ฐ์ดํ„ฐ ์ฃผ์‹ ์ฐจํŠธ
๋ถ€ํ„ฐ 1์›”(1) 2024 ์œผ๋กœ 1์›”(1) 2025 Aspyra ์ฐจํŠธ๋ฅผ ๋” ๋ณด๋ ค๋ฉด ์—ฌ๊ธฐ๋ฅผ ํด๋ฆญ.